Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alzheimer's disease

M R Chun1, R Mayeux

  • 1College of Physicians and Surgeons of Columbia University, New York, New York.

Current Opinion in Neurology
|August 1, 1994
PubMed
Summary
This summary is machine-generated.

Alzheimer's disease, a leading cause of dementia, has an unknown cause. Research explores amyloid's role, genetic links like apolipoprotein E, and risk factors such as head trauma and education.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Vascular Risk Factors on the Association of Blood-Based Biomarkers with Alzheimer's Disease.

Medical research archives·2023
Same author

Dietary fatty acids and risk of Alzheimer's disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.

Molecular psychiatry·2019
Same author

The Alzheimer's Disease Sequencing Project: Study design and sample selection.

Neurology. Genetics·2017
Same author

Genetic risk for schizophrenia and psychosis in Alzheimer disease.

Molecular psychiatry·2017
Same author

A novel Alzheimer disease locus located near the gene encoding tau protein.

Molecular psychiatry·2015
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Genetics
  • Pathogenesis of Neurodegenerative Diseases

Background:

  • Alzheimer's disease is the primary cause of dementia, with its etiology remaining elusive.
  • Amyloid's role in Alzheimer's pathogenesis is debated: is it a trigger or a consequence of cell death?
  • Genetic factors, including apolipoprotein E polymorphisms, are implicated in both sporadic and familial Alzheimer's disease.

Purpose of the Study:

  • To review current understanding of Alzheimer's disease pathogenesis.
  • To explore potential risk and protective factors associated with Alzheimer's disease.
  • To assess the current state of diagnostic and therapeutic advancements for Alzheimer's disease.

Main Methods:

  • Literature review of Alzheimer's disease research.

Related Experiment Videos

  • Analysis of genetic associations, including apolipoprotein E.
  • Examination of epidemiological data on risk factors (head trauma, education, anti-inflammatory agents).
  • Evaluation of functional imaging techniques and therapeutic interventions like tacrine.

    • Main Results:

    • Amyloid's precise role in Alzheimer's disease is unclear.
    • Apolipoprotein E gene polymorphisms are linked to Alzheimer's disease.
    • Head trauma and lower education levels increase risk; anti-inflammatory agents may reduce risk.
    • Functional imaging shows promise for understanding neural networks but lacks diagnostic markers.
    • Tacrine offers limited therapeutic benefit, and novel treatments are scarce.

    Conclusions:

    • The pathogenesis of Alzheimer's disease requires further elucidation.
    • Genetic predisposition and environmental factors significantly influence Alzheimer's risk.
    • Current diagnostic and treatment strategies for Alzheimer's disease are limited, necessitating further research and development.